Madrigal Pharmaceuticals Inc.
MDGL | NASDAQ
$431.34
+$0.98 (+0.23%)
Nov 2, 2026, 11:01 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -325.1M | -309.44M | -288.28M | -289.13M | -281.9M | -391.59M | -465.89M | -518.67M | -510.45M | -444.28M | -373.63M | -347.34M | -329.8M | -314.73M | -295.35M | -273.99M | -255.9M | -246.82M | -241.85M | -236.42M | -231.28M | -218.66M |
Depreciation & Amortization | 3.4M | 3.39M | 3.39M | 3.36M | 1.42M | 1.31M | 1.1M | 875K | 712K | 571K | 527K | 514K | 500K | 484K | 467K | 444K | 420K | 399K | 405K | 415K | 433K | 459K |
Stock-Based Compensation | 95.64M | 85.43M | 72.34M | 90.02M | 81.66M | 80.91M | 79.88M | 77.06M | 71.82M | 58.39M | 49.74M | 42.97M | 38.43M | 35.4M | 31.63M | 29.9M | 28.02M | 28.25M | 26.87M | 25.65M | 24.47M | 21.98M |
Other Working Capital | 88.59M | 76.61M | 103.86M | 175.78M | -11.24M | 2.83M | -13K | 17.57M | 8.92M | -10.19M | -7.49M | 1.1M | 6.06M | 29.26M | 35.15M | 20.62M | 16.17M | 9.38M | 10.29M | 15.4M | 17.21M | 22.45M |
Other Non-Cash Items | 100.68M | 29.43M | 31.5M | 4.85M | 2.42M | 1.53M | 1.69M | 1.9M | 2.55M | 2.64M | 2.41M | 1.97M | 1.61M | 1.23M | 797K | 31.14M | 30.83M | 30.65M | 30.65M | n/a | n/a | n/a |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -30.65M | -30.65M | -30.65M | -30.65M | n/a | n/a | n/a |
Change in Working Capital | -72.34M | -76.91M | -8.5M | 30.32M | -111.02M | -87.46M | -72.35M | 7.82M | -13.59M | -6.64M | -3.28M | -917K | 12.3M | 18.61M | 37.6M | 28.77M | 26.4M | 27.76M | 30.65M | 19.54M | 13.27M | 25.73M |
Operating Cash Flow | -197.72M | -268.1M | -189.55M | -160.58M | -307.41M | -395.31M | -455.57M | -431.02M | -448.96M | -389.32M | -324.23M | -302.81M | -276.96M | -259.01M | -224.86M | -214.39M | -200.88M | -190.4M | -183.92M | -190.81M | -193.11M | -170.48M |
Capital Expenditures | -8.57M | -4.32M | -467K | -1.05M | -974K | -6.11M | -6.46M | -7.3M | -6.86M | -1.8M | -1.48M | -472K | -166K | -200K | -217K | -301K | -318K | -217K | -209K | -106K | -59K | -64K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -50.54K | -50.54K | -50.54K | -53.54K | -68.17K | -87.51K | -87.51K | 702.49K | 767.66K | 787K | 787K | n/a | n/a | n/a |
Purchase of Investments | -997.84M | -1.07B | -1.05B | -1.18B | -1.12B | -1.18B | -1.13B | -1.26B | -908.73M | -719.81M | -834.44M | -372.33M | -317.68M | -304.73M | -143.48M | -185.44M | -286.55M | -337.97M | -394.12M | -455.53M | -399.54M | -364.42M |
Sales Maturities Of Investments | 1.06B | 1.14B | 1.08B | 1.15B | 1.08B | 975.37M | 863.28M | 674.66M | 579.63M | 504.01M | 333.4M | 298.8M | 258.77M | 268.83M | 350.38M | 341.69M | 417.76M | 422.52M | 389.27M | 430.14M | 428.77M | 440.34M |
Other Investing Acitivies | -2.91M | n/a | n/a | n/a | n/a | -5M | -5M | -5M | -4.95M | 50.54K | 50.54K | 53.54K | 68.17K | 87.51K | 87.51K | -702.49K | -767.66K | -787K | -787K | n/a | n/a | n/a |
Investing Cash Flow | 46.97M | 60.63M | 32.32M | -43.21M | -38.61M | -208.56M | -274.39M | -588.56M | -335.97M | -217.6M | -502.52M | -74.01M | -59.07M | -36.1M | 206.69M | 155.94M | 130.9M | 84.34M | -5.06M | -25.5M | 29.17M | 75.86M |
Debt Repayment | 217.93M | 217.93M | 217.93M | 218.91M | n/a | n/a | n/a | n/a | 15M | 30M | 64.79M | 64.79M | 49.79M | 84.79M | 50M | 50M | 50M | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | 10.38M | 10.38M | 10.38M | 10.38M | 48.17M | 310.32M | 554.53M | 556.38M | 514.38M | 252.24M | 16.98M | 15.13M | 8.07M | 8.07M | -341K | -334K | 552K | 1.03M | 5.11M | 5.46M | 5.57M |
Financial Cash Flow | 251.04M | 249.67M | 255.98M | 266.8M | 37.61M | 170M | 735.06M | 1.2B | 1.21B | 1.12B | 595.12M | 379.54M | 359.96M | 366.14M | 313.45M | 68.62M | 89.72M | 104.14M | 171.24M | 156.36M | 135.61M | 72.18M |
Net Cash Flow | 101.69M | 43.54M | 98.76M | 63.01M | -308.4M | -433.87M | 5.1M | 175.63M | 422.4M | 509.21M | -231.63M | 2.72M | 23.92M | 71.03M | 295.28M | 10.17M | 19.73M | -1.92M | -17.74M | -59.95M | -28.33M | -22.45M |
Free Cash Flow | -206.29M | -272.41M | -190.02M | -161.63M | -308.39M | -401.41M | -462.03M | -438.32M | -455.82M | -391.12M | -325.71M | -303.28M | -277.13M | -259.21M | -225.07M | -214.69M | -201.2M | -190.62M | -184.13M | -190.92M | -193.17M | -170.55M |
Adj. Free Cash Flow | -301.93M | -357.84M | -262.36M | -251.65M | -390.05M | -482.32M | -541.91M | -515.38M | -527.64M | -449.51M | -375.44M | -346.25M | -315.55M | -294.61M | -256.7M | -244.59M | -229.22M | -218.87M | -211M | -216.57M | -217.64M | -192.53M |
Maintenance CapEx | 13K | 394K | 780K | n/a | n/a | -3.94M | -4.3M | -4.44M | -4.58M | -703K | -381K | -268K | -166K | -200K | -217K | -294K | -311K | -210K | -202K | -106K | -59K | -64K |
Growth CapEx | -8.58M | -4.71M | -1.25M | -1.05M | -974K | -2.16M | -2.16M | -2.86M | -2.29M | -1.1M | -1.1M | -204K | n/a | n/a | n/a | -7K | -7K | -7K | -7K | n/a | n/a | n/a |
Owner Earnings | -197.7M | -267.7M | -188.77M | -160.58M | -307.41M | -399.25M | -459.87M | -435.46M | -453.53M | -390.02M | -324.61M | -303.08M | -277.13M | -259.21M | -225.07M | -214.69M | -201.19M | -190.61M | -184.12M | -190.92M | -193.17M | -170.55M |
Add to Watchlist
Select watchlists to add or remove MDGL